Document is current
Any future updates will be listed below
-
Authors
Harringa, John B.
Bracken, Rebecca L.
Markhardt, B. Keegan
Ziemlewicz, Timothy J.
Lubner, Meghan
Chiu, Arthur
Birstler, Jen
Pickhardt, Perry J.
Reeder, Scott B.
Repplinger, Michael D. https://orcid.org/0000-0002-6518-3907
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK111234, K24 DK102595)
National Center for Advancing Translational Sciences (UL1 TR000427, KL2 TR000428)
- License Information
-
More Information
Article History
Received: 14 December 2020
Accepted: 25 February 2021
First Online: 17 March 2021
Declarations
:
: MDR reports grant money from the National Institute for Diabetes and Digestive and Kidney Diseases as well as the National Center for Advancing Translational Sciences to conduct research conceived and written by himself. JBH, RLB, TJZ, ML, AC, and JB report no conflicts of interest. PJP has an advisory role with Bracco and is a shareholder in Elucent and SHINE. SBR has received grant funding from the National Institute for Diabetes and Digestive and Kidney Diseases to conduct research conceived and written by himself, is co-founder of Calimetrix, shareholder in Cellectar Biosciences and Elucent Medical, and consultant for Parexel International.
